Native T1 and T2 provide distinctive signatures in hypertrophic cardiac conditions – Comparison of uremic, hypertensive and hypertrophic cardiomyopathy

by Arcari L.; Hinojar R.; Engel J.; Freiwald T.; Platschek S.; Zainal H.; Zhou H.; Vasquez M.; Keller T.; Rolf A.; Geiger H.; Hauser I.; Vogl T.J.; Zeiher A.M.; Volpe M.; Nagel E.; Puntmann V.O.
Published in International Journal of Cardiology (2020)

CMR imaging biosignature of cardiac involvement due to cancer-related treatment by T1 and T2 mapping

by Haslbauer J.D.; Lindner S.; Valbuena-Lopez S.; Zainal H.; Zhou H.; D'Angelo T.; Pathan F.; Arendt C.A.; Bug G.; Serve H.; Vogl T.J.; Zeiher A.M.; Carr-White G.; Nagel E.; Puntmann V.O.
Published in International Journal of Cardiology (2019)